Wolwo Pharma Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 1,808

Employees

  • Stock Symbol
  • 300357

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $3.25
  • (As of Friday Closing)

Wolwo Pharma General Information

Description

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is engaged in Research, development, production and sales of biopharmaceutical products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Wukang Town
  • Deqing County
  • Huzhou, Zhejiang 313200
  • China
+86 157
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Wukang Town
  • Deqing County
  • Huzhou, Zhejiang 313200
  • China
+86 157

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Wolwo Pharma Stock Performance

As of 13-Nov-2026, Wolwo Pharma’s stock price is $3.25. Its current market cap is $1.7B with 524M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.25 $3.28 $2.77 - $4.76 $1.7B 524M 10M $0.12

Wolwo Pharma Financials Summary

As of 30-Sep-2026, Wolwo Pharma has a trailing 12-month revenue of $162M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,402,724 1,946,139 1,307,818 1,991,862
Revenue 162,352 147,734 128,967 119,888
EBITDA 68,412 64,734 53,679 50,144
Net Income 62,002 52,972 44,293 43,843
Total Assets 479,894 414,109 371,108 361,449
Total Debt 1,812 2,631 3,505 8,809
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Wolwo Pharma Patents

Wolwo Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230022218-A1 Method and kit for detecting human papillomaviruses Pending 13-Dec-2019
EP-4074843-A1 Method and test kit for detecting human papillomavirus Active 13-Dec-2019
EP-4074843-A4 Method and test kit for detecting human papillomavirus Active 13-Dec-2019
EP-4074843-B1 Method and test kit for detecting human papillomavirus Active 13-Dec-2019
EP-4074843-C0 Method and test kit for detecting human papillomavirus Active 13-Dec-2019 C12Q1/708
To view Wolwo Pharma’s complete patent history, request access »

Wolwo Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Wolwo Pharma Investments (2)

Wolwo Pharma’s most recent deal was a Secondary Transaction - Private with Kaiyi Pharmaceutical. The deal was made on 21-Jul-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Kaiyi Pharmaceutical 21-Jul-2021 Secondary Transaction - Private Pharmaceuticals
Kaiyi Pharmaceutical 30-Sep-2017 Secondary Transaction - Private Pharmaceuticals
To view Wolwo Pharma’s complete investments history, request access »

Wolwo Pharma ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

34.77 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Biotechnology

Subindustry

of 431

Rank

Percentile

To view Wolwo Pharma’s complete esg history, request access »

Wolwo Pharma FAQs

  • When was Wolwo Pharma founded?

    Wolwo Pharma was founded in 2002.

  • Where is Wolwo Pharma headquartered?

    Wolwo Pharma is headquartered in Huzhou, China.

  • What is the size of Wolwo Pharma?

    Wolwo Pharma has 1,808 total employees.

  • What industry is Wolwo Pharma in?

    Wolwo Pharma’s primary industry is Pharmaceuticals.

  • Is Wolwo Pharma a private or public company?

    Wolwo Pharma is a Public company.

  • What is Wolwo Pharma’s stock symbol?

    The ticker symbol for Wolwo Pharma is 300357.

  • What is the current stock price of Wolwo Pharma?

    As of 13-Nov-2026 the stock price of Wolwo Pharma is $3.25.

  • What is the current market cap of Wolwo Pharma?

    The current market capitalization of Wolwo Pharma is $1.7B.

  • What is Wolwo Pharma’s current revenue?

    The trailing twelve month revenue for Wolwo Pharma is $162M.

  • What is Wolwo Pharma’s annual earnings per share (EPS)?

    Wolwo Pharma’s EPS for 12 months was $0.12.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process